Western Infirmary, Glasgow, between January 1988 and July (CVD, a subgroup of D). Differences between patients in 1990. The current analysis was performed in May 1996. groups A vs D, and CVD vs the rest, were expressed using Patients were included if they had developed end-stage renal Wilcoxon confidence intervals for median differences between failure in adult life and were excluded if they had diabetic groups (for numerical data) and confidence intervals for the nephropathy, rheumatic or congenital heart disease, or other difference in proportions (for categorical data). These tests systemic diseases involving the heart. All patients gave were performed using the MINITAB statistics package. informed consent and the study was approved by the Western Survival analysis was then performed using the Cox proporInfirmary Ethical Committee.
tional hazard model to identify factors related to cardiovasOf the 141 eligible patients, 34 have since died, 22 of cular death. Factors identified in univariate analysis were cardiovascular causes (stroke, myocardial infarction, heart included in a multivariate analysis, and models identifailure or sudden death). The other causes of death included fied using forward and backward stepwise regression. sepsis, malignancy and suicide. In the analysis, the deaths Kaplan-Meier survival curves were also generated; comparhave been examined as a whole group and as a subgroup of ison of the survival curves above and below the median value cardiovascular deaths (CVD) only.
was by the log-rank test (Figure 1 ). The SPSS statistics package (SPSS Inc., USA) was used for these analyses [8] .
Patient data
Full medical details and clinical examination findings were recorded prior to transplantation. Blood pressure was meas-
Results
ured by one observer ( EM ) using a standard mercury sphygmomanometer. Routine haematological and biochemical tests were performed including serum cholesterol. Of 141 patients who underwent echocardiography, 120 Body surface area was determined from height and had traces which were of adequate clarity to determine weight according to Boyd's formula: BSA=3.2×ht0.3× LV dimensions and mass. The summary data from all wt{0.7285-0.0188*log10(wt)}/104m2.
patients are shown in Table 1a . One hundred and seven patients were still alive in May 1996, a median of Echocardiography 7.5 years after renal transplantation and 82 of these had functioning renal allografts. Thirty-four patients M-mode, two-dimensional and Doppler echocardiographic examination was undertaken by a single observer ( EM ) had died, 22 of cardiovascular disease. The median using a Hewlett-Packard ultrasound unit (model 77020A) time to death following transplantation was 2.1 years with a 2.5 MHz transducer. Patients were studied in the left and the median age at death was 55.7 years. Overall decubitus position with the probe in the third to the fifth the median follow-up was 6.5 years.
intercostal space. All scans were recorded on video and, in the case of M-mode tracings, also on light sensitive paper at 50 mm/s. These recordings were coded and later analysed blindly by the operator ( EM ). Repeated echocardiographic Echocardiographic data measurements made on 10 occasions in a single subject, gave
Left ventricular mass measurements were increased coefficients of variation of 4.9 and 4.3% for left ventricular mass and volume respectively. Independent, blinded analysis with a median value of 144 g/m2 in all patients. of a selection of traces by a second echocardiographer gave Although there were no normal control subjects in the a correlation of 0.98 for LV mass. Traces which were suitable present study, accepted upper limit of normal LV mass for determination of LV mass were analysed using a digitizing values from the Framingham population are tablet ( Kontron Ltd, UK ) and a microcomputer (Cardio 134-143 g/m2 for men and 100-102 g/m2 for women 80 ively [5] . The median septal thickness was also Left ventricular volumes at end-diastole (EDV ) and endincreased at 1.6 (0.7-4.5) cm, although there was little systole (ESV ) were estimated according to the method of Tortoledo et al. [7] . Values are also given for end-diastolic difference in the posterior wall thickness, indicating diameter (EDD) and end-systolic diameter (ESD). From that hypertrophy was asymmetrical.
these measurements, indices of systolic function, ejection
In the group as a whole, fractional shortening was fraction (EF=( EDV-ESV )/EDV ) and fractional shortening low at 31 (5-53)%, although the calculated ejection (FS=( ESD-EDD)/EDD), were calculated. fraction was not with a median value of 54 (26-83)%. The median E5A ratio, a measure of diastolic dysfuncAnalysis tion, was 0.84 (0.37-5.07), suggesting that diastolic dysfunction is not of major importance in this populaIn the initial analysis, patients were divided into three groups:
alive (A), dead (D) and dead from cardiovascular disease tion, although it is present in some patients. Data are shown as median (range), n is the number of individuals. Age (age in years at time of transplant), BMI (body mass index), HBP (number of treated hypertensives); SBP, MBP, DBP (systolic, mean and diastolic blood pressure, mmHg); Smoking (number of current ( Y ), non (N ) and ex ( EX ) cigarette smokers); Previous MI (number of previous myocardial infarctions); Hb (haemoglobin, g/dl ), Cholesterol (serum cholesterol, mmol/l ), TG (serum triglycerides, mmol/l ). Echocardiographic measurements: LVMI ( left ventricular mass measurements, g/m2), IVST, PWT (interventricular septal and posterior wall thickness, cm); EDD, ESD (end systolic and 5end diastolic diameters, cm); ESV, EDV (end systolic and end diastolic volumes, ml ); FS (fractional shortening), EF (ejection fraction), E5A (E5A ratio).
Outcome and echocardiographic measures shortening was lower at the time of transplantation in the patients who subsequently died ( Table 1a , b). The Comparison of the echocardiographic findings in sur-observed differences were more pronounced in patients vivors and non-survivors (summarized in Table 1 ), who died of cardiovascular disease. revealed that median LVMI was significantly higher in the patients who died (167 vs 134 g/m2, respectively).
Survival curves for ventricular size and function The LVMI of patients who died from cardiovascular causes was highest (177 g/m2). Ventricular dimensions An alternative method of examining the influence of showed a similar pattern: EDD was increased with a echocardiographic measurements is to subdivide the median value of 5.9 cm (CVD) and 5.8 cm (all deaths), patients according to the parameter of interest and compared with 5.2 cm in the survivors. The corres-then perform survival analysis. The choice of a cut-off ponding values for ESD were 4.7, 4.3 and 3.4 cm. to define left ventricular hypertrophy or systolic dysInterestingly, there were no differences in the derived function is arbitrary, but we examined the survival of measurements of LV volume, which in view of the patients subdivided into two groups by the median large observed differences in LV diameter could reflect value of left ventricular mass index. Kaplan-Meier either difficulties in accurate measurement of the appro-survival curves are shown in Figure 1A (LVMI, priate ventricular axes or deficiencies in this method P<0.01). Echocardiographic ventricular diameter and of assessment in patients with renal failure. Not surpris-FS were also related to survival in a similar fashion ingly, in view of these findings ejection fraction, which ( Figure 1B, C: FS, P<0.01; ESD, P<0.01) . is the ratio of end-systolic and end-diastolic volumes, was not significantly different in survivors and non-Other risk factor data survivors. However, the more direct index of ventricular systolic function, fractional shortening ( FS [10]), It is essential to examine the role of echocardiographic measurements in the context of other recognized risk was significantly impaired in the patients who died. Their median fractional shortening was 27 and 23% in factors for cardiovascular death such as hypertension, hyperlipidaemia, cigarette smoking and previous carthose patients whose death was due to CVD, compared with 33% in surviving patients. The E5A ratio, a diac disease. These data are also shown in Table 1 .
The most striking difference in any parameter was age measure of diastolic function, was lower in the patients who died, but this failed to achieve statistical signific-at the time of transplantation. As has previously been reported [5] this was the most significant difference ance. In summary, these analyses show that LVMI and LV diameter were greater and that fractional with an overall median value of 39 years; 37 years in the survivors, 53 years in the patients who died and 53 years in those who died of cardiovascular disease (P<0.01 dead vs alive and P<0.01 CVD vs rest). There were no significant differences in the other recognized cardiovascular risk factors ( Table 1b) ; hypertension, blood pressure measurements or in either total cholesterol or triglycerides (although these data are incomplete). The proportion of cigarette smokers was high at 37% overall, 37% in the survivors, 39% in the dead group, 38% in the CVD. The proportion of patients who had had a previous myocardial infarction was low, and there was no significant difference between the groups. Finally, there were no significant differences in the sex ratio, body mass index or haemoglobin. The latter measurement is of particular relevance as the severity of anaemia [11] is one factor known to influence LVMI.
Multivariate analysis
Since age is an irremediable risk factor we therefore attempted, as others have done [5] , to determine the relative importance of all parameters including echocardiographic measurements on outcome using the Cox proportional hazards method [8] . These data are shown in Tables 2 and 3 . In the initial analysis of cardiovascular deaths (CVD) six factors (of those listed in Table 1 ) were shown to be significantly associated with survival: age, ESD, FS, EDD, LVMI and EF. These findings are similar to those of Silberberg et al.
[5] in a dialysis population. Stepwise regression analysis [8] , to identify independent determinants of outcome ( Table 3 ), revealed that age was the most important association. ESD and systolic function ( FS) were also independent predictors of outcome.
Discussion
In this study we have examined the prognostic importance of echocardiographic left ventricular dimensions, mass and function at the time of renal transplantation in a cohort of patients followed for a median of 7.5 years.
Echocardiographic data
Left ventricular mass was increased before renal transplantation with a median value of 144 g/m2. Although there were no normal control subjects, accepted upper limits of LV mass in the Framingham population are 131-143 g/m2 for men and 100-102 g/m2 for women [9] . These cut-off values would categorize 64-70% of men and 63-65% of women in the present study as having LVH. Previous reports in patients on dialysis have demonstrated an increased prevalence of LVH. co-efficient [11] , RR the relative hazard ratio (exp b) with 95% dysfunction to those patients with a fractional confidence intervals and P-value in adjacent columns.
shortening of less than 25% [12] , which in our series would include 33/119 (28%) of patients. Thus, our Table 3 . Independent associations following stepwise regression ana-findings in a selected pre-transplant population confirm lysis, Cox proportional hazards model, for CVD a similar pattern of echocardiographic cardiac abnormalities to that previously reported in dialysis popula- One criticism of the current study is that it was not removal by ultrafiltration. The derived measurements, including ventricular volume and left ventricular mass, 332) respectively (median(range)). In addition to LVH, will therefore be influenced by volume status and can two other major left ventricular abnormalities have differ by up to 10% before and after haemodialysis been recognized-left ventricular dilatation and with volume removal [13] . Ideally patients should be reduced systolic function. Parfrey and colleagues have studied at or close to their dry weight and Parfrey reported prevalences of 28 and 16% respectively for recommends that patients should be studied on the these echocardiographic patterns of cardiac disease in day following haemodialysis [13] . By chance, about dialysis patients. In our study, end-diastolic diameter half the patients in the present study would have was increased (5.3 (3.0-7.5) cm), similar to dimensions complied with this recommendation; the remainder were studied on the day of routine haemodialysis or reported by Silberberg and colleagues [5] . End-systolic following a short, pre-transplant treatment. CAPD diameter and FS were clearly abnormal and related to outcome, measurements of chamber volume and estimpatients are less subject to shifts in fluid status, yet might not have been at their ideal dry weight when ated ejection fraction ( Table 1) , and E5A ratio (a measure of diastolic dysfunction) did not exhibit the studied. Although the absolute LV dimensions might have been affected, the conclusions of the study are same strength of relationship. This may reflect the unreliable nature of derived echocardiographic indices unlikely to be altered.
in this population, and also the available technology at the time when this study was performed. It is Outcome possible that measurements of left ventricular volume and function using today's echocardiographic equipOf the original cohort of patients, 34 have died. Left ventricular mass index was significantly higher, by ment and analytical software would provide more consistent results [17] . about 30 g/m2, in the patients who died compared with who are still alive ( Table 1) . When patients were Several questions arise from the echocardiographic abnormalities identified: (a) what are the mechanisms stratified according to LVMI there were twice as many deaths in the group with LVMI above the median underlying the echocardiographic abnormalities?
(b) how do they contribute to mortality? (c) can they ( Figure 1A ). Subdivision of patients by LVMI, or other echocardiographic parameters is arbitrary. be corrected? and (d ) how do they relate to other risk factors for cardiovascular disease? Silberberg used a value of 125 g/m2 for LVMI [5] , close to the mean value for their patient group, while
In the general population, the major determinants of LV mass are blood pressure and age [9] . There were Parfrey used Framingham figures of 132 g/m2 for men and 100 g/m2 for women [8, 12] both demonstrated a no relationships between mean BP and LV mass or between age and LV mass in our study. The lack of clear effect of increased LVMI and adverse outcome. Our data confirm these previous findings in dialysis relationship with BP may reflect the inadequacy of casual recordings and 24 h ambulatory monitoring populations but show that despite any possible beneficial effects of renal transplantation on the left ventricle may be more informative as it is following transplantation [18] and in progressive renal disease [19] . [15, 16 ] . The presence of increased left ventricular diameter or mass, and reduced fractional shortening, Alternatively, there may be blood pressureindependent effects of uraemia on the heart, perhaps on the eve of renal transplantation is associated with a poor outcome. Fractional shortening was signific-mediated through interstitial fibrosis [20] . The reliance of the measurement of LVMI on chamber diameter, antly less in patients who died, with a median value of just 23% in the patients who died of cardiovascular and the potential bias this places on calculated LVMI, may also obscure true relationships. ESD and EDD causes. The importance of poor systolic function is demonstrated in Figure 1B which depicts the effect on are dependent on the intravascular volume of the patients and were increased in patients who died. survival of subdividing the patients by the median FS. The end-systolic and end-diastolic dimensions were Parfrey has suggested that dilated ventricular chambers are a result of impaired LV function, and thus indicatalso increased in patients who subsequently died ( Table 1 ) consistent with previous reports [5, 12] . The ive of a dilated cardiomyopathy, although ventricular dilatation due to volume expansion may result in effect of ESD on survival is shown in Figure 1C . Measurements of chamber diameter, and mass meas-apparent systolic dysfunction. Further studies will be required to establish the relative importance of cardiac urements derived from these, are obviously interrelated and it may be inappropriate to assess these function and intravascular volume [13] . Regardless of these considerations, FS and ESD were clearly associparameters independently. Thus, although our data may be interpreted as showing the three patterns of ated with patient outcome ( Figure 1B, C ) . and whether this reflects primary cardiac disease, or poor fluid 'cardiomyopathy' described by Parfrey et al. [12] , these may be artificial subdivisions reflecting inter-related balance control, it still identifies a potential target for intervention. Future studies will determine whether underlying abnormalities.
At the outset, the primary aim of this study, was to improved control of fluid balance or of blood pressure can cause regression of LVH or normalization of examine the role of LVH (LVMI ) on outcome. However, the analysis ( Tables 2, 3 ) identified ESD as chamber diameters and, in the long term, whether this improves patient outcome. a more significant and independent predictor of CVD. Previous studies have also shown that increased ESD Sudden death is the most common mode of death in patients on RRT, reflecting the increased susceptibilis associated with adverse outcome [5, 13] although this just failed to achieve statistical significance in the study ity of the dilated or hypertrophied heart to develop arrhythmias. Alternatively, repeated and excessive of Silberberg and colleagues [5] . Ventricular dilatation may contribute to the higher calculated LVMI [6 ] and ventricular dilatation may produce intractable left ventricular failure, which is known to be associated may conceivably be the most important abnormality. Further studies will be required to validate the meas-with adverse outcome in patients on dialysis [12] .
The final question relates to the place of echocardiourements of LVMI made using echocardiography in patients on dialysis and to compare this method with graphic findings with other known risk factors for CVD. As in previous studies, age was the strongest other techniques such as magnetic resonance imaging. A related observation is that, although chamber determinant of outcome in the univariate analysis and
